Company attributes
Other attributes
Perceiv AI, located in Montreal, Quebec, Canada & founded in 2018, is an artificial intelligence company focused on the identification and understanding of genetic biomarkers to optimize the diagnosis and treatment process for different illnesses.
Perceiv is pursuing the development of an application for Alzheimer's Disease as well as cardiovascular diseases. Additionally, the Perceiv AI algorithms and machinery is being used in conjunction with the development of drugs within the pharmaceutical industry.
The algorithms are used to test heterogeneous populations using multimodal data to characterize patients by phenotypes. Once the phenotypes are characterized, the patients are then sorted using a precision tool that sorts them into sub-groups for potential risk and effect of an illness or drug.
